Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

310.87

Today's Change

+2.43 (0.78%)

Day's Change

302.16 - 311.18

Trading Volume

188,249

Overview

Market Cap

6 Billion

Shares Outstanding

21 Million

Avg Volume

428,509

Avg Price (50 Days)

288.88

Avg Price (200 Days)

256.99

PE Ratio

-12.41

EPS

-25.04

Earnings Announcement

26-Feb-2025

Previous Close

308.44

Open

310.81

Day's Range

302.16 - 311.18

Year Range

168.25 - 368.29

Trading Volume

194,625

Price Change Highlight

1 Day Change

0.79%

5 Day Change

1.49%

1 Month Change

-10.53%

3 Month Change

37.72%

6 Month Change

11.66%

Ytd Change

37.03%

1 Year Change

31.55%

3 Year Change

256.26%

5 Year Change

235.13%

10 Year Change

240.31%

Max Change

-2.29%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment